Focusing On New Directions Of Viral Hepatitis Care And ResearchThe editors of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue. Published each May, the 13th issue is devoted to a particular gastroenterological topic of broad interest; this year's topic is viral hepatitis. In conjunction with editor-in-chief M...
Good News And Bad News In Fatty Liver Disease And DiabetesA Penn research team, led by Mitchell Lazar, MD, PhD, director of the Institute for Diabetes, Obesity, and Metabolism at the Perelman School of Medicine, University of Pennsylvania, reports in Nature Medicine that mice in which an enzyme called histone deacetylase 3 (HDAC3) was deleted had massively fatty livers, but lower blood sugar, and were thus protected from glucose intol...
Comorbidities Increase Risk Of Mortality In COPD Patients A new study published online in the American Journal of Respiratory and Critical Care Medicine reveals that comorbidities amongst patients with chronic obstructive pulmonary disease (COPD) are common, and that several of these comorbidities are independently linked to a higher risk of mortality...
Growth Of Hepatocellular Carcinoma Halted By Combining Two MTOR InhibitorsThe combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL). The study results are been published on the online edition of the journal Science Translational Medicine...
Interferon For Hepatitis C Can Cause DepressionThere's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression. In a review article, researchers tackle the complexities of diagnosing and managing depression before and after initiating treatment with interferon. Dr. Murali S...
FDA Update Safety Information On HIV Drug Victrelis (Boceprevir) The United States Food and Drug Administration (FDA) is updating information on Victrelis (boceprevir). The drug is used as a hepatitis C (HCV) protease inhibitor. It is combined with various ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors...